Institute of Bioengineering and Bioimaging (IBB)

Imaging experts discover a non-invasive method to identify which patients with liver cancer are most likely to respond to immunotherapy.

Game-changing new ideas and products are born from connecting the right minds and hands. In this cover story, we spotlight how A*STAR facilitates those connections and cultivates the culture needed for an ecosystem of innovation.

Non-invasive imaging technology reveals how radiation exposure in the brain, particularly early in life, damages delicate brain tissue.

A head-to-head test of three common mask decontamination methods helps frame standardised national guidelines.

New self-cleaning surfaces created by A*STAR researchers take inspiration from cicada wings to attract and destroy microbes without harsh chemicals.

Synthetic DNA molecules could serve as an easy-to-manufacture alternative to traditional antibody-based rapid tests.

A*STAR scientists develop an optoacoustic imaging technology for diagnosing disease by assessing subtle blood flow changes in the skin.

By identifying the best way to decontaminate N95 masks, A*STAR scientists are helping solve the environmental consequences of disposable masks.

A phenomenon called superferromagnetism boosts the resolution of magnetic particle imaging.

A*STAR scientists developed self-sanitizing surfaces capable of eliminating microbes effectively within mere minutes.

Researchers have identified a stem cell marker that influences fat cell development, unlocking exciting therapeutic opportunities for chronic diseases.

A novel polymer improves the effectiveness of chemotherapeutics against drug-resistant tumors.